Arizona law intended to limit opioid prescriptions may hurt chronic pain patients

States are desperate to act in response to the national opioid epidemic, but laws limiting opioid prescriptions and doses are negatively impacting chronic pain patients and leaving doctors conflicted about care delivery, NPR reported.

More than two dozen states have implemented laws aimed at curbing the opioid addiction crisis, including Arizona, which recently passed the Arizona Opioid Epidemic Act in a unanimous vote. The new state law has made the reduction of opioids “fast and furious,” NPR reported.

“Since the passage of the law, some doctors in Arizona report feeling pressure to lower patient doses, even for patients who have been on stable regimens of opioids for years without trouble,” according to NPR.

Read the full story here.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.